On Friday, Goldman Sachs (NYSE: GS) analysts initiated coverage on Teva Pharmaceutical Industries Ltd. (NYSE: NYSE: TEVA) with a Buy rating and set a price target of $24.00.The analysts highlighted an ...

On Friday, Goldman Sachs analysts initiated coverage on Teva Pharmaceutical (TADAWUL: 2070) Industries Ltd. (NYSE: NYSE: TEVA) with a Buy rating and set a price target of $24.00.The analysts ...

On Friday, Goldman Sachs (NYSE: GS) analysts initiated coverage on Teva Pharmaceutical (TADAWUL: 2070) Industries Ltd. (NYSE: NYSE: TEVA) with a Buy rating and set a price target of $24.00.The ...

SHANGHAI, June 5, 2025 /PRNewswire/ -- The 2025 ASCO Annual Meeting successfully concluded in Chicago on June 3 (local time). Hengrui Pharma delivered a strong international presence, featuring 15 ...

American pharmaceutical giant Cosette has terminated its $672 million takeover bid for Adelaide-headquartered drug company Mayne Pharma, but the target company says it will challenge the move in ...

Sun Pharma's shares experienced a 0.47 per cent decline, trading at Rs 1,659.80, alongside the sharper fall in SPARC shares to Rs 156.50 on the BSE.

The pharma package. The proposals for a regulation and directive that make up the so-called ‘pharma’ package constitute the biggest reform to the EU’s laws on medicines in over two decades. They aim ...